Daniel Joseph OConnell

Chief Executive Officer, Director, Acumen Pharmaceuticals, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.2M

Companies

Latest trade

Jan 22, 2026

Companies

Acumen Pharmaceuticals, Inc.Chief Executive Officer, Director −$0.2M

Trades

ABOS Sold 2,689 shares at $1.88 · planned $0.0M Jan 22

ABOS Sold 9,346 shares at $1.81 · planned $0.0M Jan 21

ABOS Sold 5,388 shares at $1.73 · planned $0.0M Jan 12

ABOS Sold 12,941 shares at $1.76 · planned $0.0M Jan 9

ABOS Sold 8,143 shares at $1.82 · planned $0.0M Jan 8

ABOS Sold 37,755 shares at $1.99 · planned $0.1M Jan 7

ABOS Sold 5,102 shares at $1.97 · planned $0.0M Jan 6

ABOS Sold 4,649 shares at $1.97 · planned $0.0M Jan 5

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.